Stress urinary incontinence is a common complication after radical prostatectomy or prostate outlet surgery that can have a lasting impact on quality of life. Incontinence rates are typically higher after radical prostatectomy, ranging from 59% 6 weeks after surgery to 22% 58 weeks after surgery, as compared to 2.2% after most benign outlet procedures. While continence may improve for up to 12 months after radical prostatectomy, approximately 20% of patients do not return to baseline urinary function. The male artificial urinary sphincter (AUS) is commonly regarded as the “gold standard” treatment for any degree of urinary incontinence after prostate surgery. However, for mild-to-moderate urinary incontinence, several other treatment options are available. The AdVance Male Sling System™ (Boston Scientific, Minnetonka, MN) for the treatment of mild-to-moderate male urinary incontinence was approved by the FDA in 2006 and offers success rates of up to 70–90% in appropriately selected individuals. The AdVance Sling is a transobturator (TOT)-placed suburethral polypropylene monofilament mesh. Helical trocars are used for transobturator passage to facilitate sling placement. A second iteration of the sling, the AdVance™ XP, was subsequently released in 2010 featuring polypropylene tissue anchors for enhanced fixation. Ultimately, the sling works to reposition the urethra to immediately improve continence.